Medicare Enrolled
Dr. Bruce Cotugno, M.D.
Neurology · Washington, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cotugno from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cotugno?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cotugno
Dr. Bruce Cotugno is a neurology specialist in Washington, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cotugno performed 32,462 Medicare services across 973 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cotugno received a total of $308,793 from 85 pharmaceutical and/or device companies across 2224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cotugno is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in PA
$308,793 industry payments
Medicare Practice Summary
Medicare Utilization ↗32,462
Medicare services
Top 0% in PA for neurology
973
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,623 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
22,195 | $5 | $10 |
| Inclisiran injection (Leqvio) for cholesterol | 8,804 | $9 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
390 | $86 | $185 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
259 | $57 | $130 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
99 | $116 | $310 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
96 | $94 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
90 | $10 | $45 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
85 | $46 | $250 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
73 | $1 | $15 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 72 | $40 | $197 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
64 | $74 | $350 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
55 | $115 | $600 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
41 | $126 | $300 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
39 | $59 | $175 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
36 | $75 | $206 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
36 | $202 | $450 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $78 | $185 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
13 | $317 | $550 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$308,793
Total received (2018-2024)
Avg $44,113/year across 7 years
Top 3% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
85
Companies
2,224
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$258,355 (83.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$34,620 (11.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,818 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$17,200
2023
$24,298
2022
$74,082
2021
$58,827
2020
$29,811
2019
$52,122
2018
$52,453
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$6,441
GENZYME CORPORATION
$4,851
UCB, Inc.
$765
Teva Pharmaceuticals USA, Inc.
$424
SK Life Science, Inc.
$357
ACADIA Pharmaceuticals Inc
$352
Novartis Pharmaceuticals Corporation
$344
MDD US Operations, LLC
$344
Eisai Inc.
$291
EMD Serono, Inc.
$285
ARGENX US, INC.
$275
Otsuka America Pharmaceutical, Inc.
$242
E.R. Squibb & Sons, L.L.C.
$238
JAZZ PHARMACEUTICALS INC.
$238
Lilly USA, LLC
$235
Amgen Inc.
$212
PFIZER INC.
$179
Alnylam Pharmaceuticals Inc.
$163
Genentech USA, Inc.
$158
Alexion Pharmaceuticals, Inc.
$149
MITSUBISHI TANABE PHARMA AMERICA, INC.
$135
Kyowa Kirin, Inc.
$100
Celgene Corporation
$79
LivaNova USA, Inc.
$40
Amneal Pharmaceuticals LLC
$37
Lundbeck LLC
$37
Neurocrine Biosciences, Inc.
$32
REVANCE THERAPEUTICS, INC.
$30
Biogen, Inc.
$26
Sumitomo Pharma America, Inc.
$24
Abbott Laboratories
$24
Grifols USA, LLC
$22
Neurelis, Inc.
$20
Acorda Therapeutics, Inc
$19
Collegium Pharmaceutical, Inc.
$17
GE HEALTHCARE
$14
Top 3 companies account for 70.1% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$82,256
GENZYME CORPORATION
$61,129
Biohaven Pharmaceuticals, Inc.
$22,908
ABBVIE INC.
$19,900
EMD Serono, Inc.
$18,821
Genentech USA, Inc.
$18,650
Allergan, Inc.
$16,424
AbbVie Inc.
$15,708
Biohaven Pharmaceutical Holding Company Ltd.
$15,079
LivaNova USA, Inc.
$4,223
Novartis Pharmaceuticals Corporation
$3,511
Teva Pharmaceuticals USA, Inc.
$2,797
UCB, Inc.
$2,293
E.R. Squibb & Sons, L.L.C.
$2,089
Genentech, Inc.
$1,798
SK Life Science, Inc.
$1,557
Acorda Therapeutics, Inc
$1,142
ACADIA Pharmaceuticals Inc
$1,097
Amgen Inc.
$1,090
Allergan Inc.
$874
Janssen Pharmaceuticals, Inc
$741
Neurocrine Biosciences, Inc.
$721
Avanir Pharmaceuticals, Inc.
$719
US WorldMeds, LLC
$671
Neurelis, Inc.
$615
Jazz Pharmaceuticals Inc.
$613
ARGENX US, INC.
$598
MDD US Operations, LLC
$581
Celgene Corporation
$556
Eisai Inc.
$550
Sunovion Pharmaceuticals Inc.
$548
Amneal Pharmaceuticals LLC
$526
Alexion Pharmaceuticals, Inc.
$509
JAZZ PHARMACEUTICALS INC.
$494
Greenwich Biosciences, Inc.
$484
Lilly USA, LLC
$480
Lundbeck LLC
$470
PFIZER INC.
$467
Otsuka America Pharmaceutical, Inc.
$409
Mallinckrodt LLC
$380
Mallinckrodt Enterprises LLC
$366
Adamas Pharmaceuticals, Inc.
$308
Kyowa Kirin, Inc.
$306
Supernus Pharmaceuticals, Inc.
$265
CSL Behring
$264
IMPEL PHARMACEUTICALS INC.
$245
MITSUBISHI TANABE PHARMA AMERICA, INC.
$215
Alnylam Pharmaceuticals Inc.
$210
Boston Scientific Corporation
$190
Impax Laboratories, Inc.
$162
Mallinckrodt Hospital Products Inc.
$152
Ipsen Biopharmaceuticals, Inc
$142
ARBOR PHARMACEUTICALS, INC.
$127
Sumitomo Pharma America, Inc.
$110
W. L. Gore & Associates, Inc.
$97
Horizon Therapeutics plc
$88
GRT US Holding, Inc.
$84
GE HealthCare
$77
Abbott Laboratories
$66
Bausch Health US, LLC
$66
Currax Pharmaceuticals LLC
$66
Grifols USA, LLC
$57
GE HEALTHCARE
$57
Vertical Pharmaceuticals, LLC
$55
BANNER LIFE SCIENCES, LLC
$54
GE Healthcare
$41
SANOFI-AVENTIS U.S. LLC
$37
NEUROPACE, INC.
$33
REVANCE THERAPEUTICS, INC.
$30
Upsher-Smith Laboratories LLC
$30
Scilex Pharmaceuticals Inc.
$28
BOSTON SCIENTIFIC CORPORATION
$28
Arbor Pharmaceuticals, Inc.
$27
Catalyst Pharmaceuticals, Inc.
$25
kaleo, Inc.
$24
Merz North America, Inc.
$22
Promius Pharma LLC
$22
Merz Pharmaceuticals, LLC
$20
Merck Sharp & Dohme LLC
$18
Octapharma USA, Inc.
$17
Collegium Pharmaceutical, Inc.
$17
UPSHER-SMITH LABORATORIES LLC
$17
TG THERAPEUTICS, INC.
$17
Merck Sharp & Dohme Corporation
$16
Alfasigma USA, Inc.
$14
Top 3 companies account for 53.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · CONTRAVE · COPAXONE · Cenobamate · Cimzia · DAXXIFY · DISEASE STATE · DUOPA · DYSPORT · Dysport · EMGALITY · EPIDIOLEX · EVZIO · Edarbi · Epidiolex · FIRDAPSE · Fintepla · Fycompa · GENERAL DBS · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · Gamunex-C · General - DBS · Gocovri · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · Kcentra · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONFI · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · Ponvory · QULIPTA · Qutenza · RADICAVA · REXULTI · RNS Neurostimulator Kit · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · Skyclarys · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WATCHMAN · XCOPRI · XEOMIN · XTAMPZA · Xadago · Xeomin · ZEPOSIA · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in PA.
Geographic Context
Neurologists within 10 mi
102
Per 100K population
48.6
County median income
$77,487
Nearest hospital
WASHINGTON HOSPITAL, THE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cotugno is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with speaking/promotional industry engagement in the top 3% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cotugno experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Cotugno performed 22,195 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cotugno receive payments from pharmaceutical companies?
Yes. Dr. Cotugno received a total of $308,793 from 85 companies across 2,224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cotugno's costs compare to other neurologists in Washington?
Dr. Cotugno's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cotugno) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Washington
Browse neurologists in Washington ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in PA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in PA
Which PA neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology